Ftse Mib
39.022,40
0,00%
DAX
23.154,57
0,94%
S&P 500
5.675,12
0,64%
NASDAQ
17.808,66
0,31%
Bitcoin
83.070,54
-1,18%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Nevro Corp (NVRO) Nevro Corp (NVRO) Notizie

Nevro Corp

NVRO
5,78
0,00 (0,00%)
18 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
11/3/202522:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202522:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202522:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202522:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/3/202522:03EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
10/3/202513:57EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
04/3/202523:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202523:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202523:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202522:17EDGAR2Form 8-K - Current report
04/3/202522:15PRNUSNevro Reports Fourth-Quarter and Full-Year 2024 Financial..
21/2/202522:59EDGAR2Form PREM14A - Preliminary proxy statements relating to..
21/2/202519:17PRNUSKuehn Law Encourages NVRO, SLRN, TGI, and PTMN Investors to..
20/2/202523:10EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
14/2/202523:14EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
14/2/202519:09EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
10/2/202515:11PRNUSKuehn Law Encourages NVRO, SLRN, TGI, and PTMN Investors to..
06/2/202522:07EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/2/202522:05EDGAR2Form 8-K - Current report
06/2/202515:30GLOBEGlobus Medical to Acquire Nevro Corp. to Expand Treatment..
27/1/202522:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/1/202522:30PRNUSNevro Announces New Employee Inducement Grants Under NYSE..
14/1/202518:29EDGAR2Form 8-K - Current report
13/1/202514:30PRNUSNevro Announces Preliminary Fourth-Quarter and Full-Year..
06/1/202522:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202522:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202422:30PRNUSNevro Announces New Employee Inducement Grants Under NYSE..
09/12/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202422:27EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
02/12/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202414:30PRNUSNew Study Demonstrates Multiple Advantages of Nevro1™, the..
15/11/202414:30PRNUSNevro Announces New Employee Inducement Grants Under NYSE..
14/11/202423:31EDGAR2Form SC 13D/A - General Statement of Acquisition of..
14/11/202423:18EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202422:11EDGAR2Form 8-K - Current report
12/11/202413:00PRNUSNevro's HFX iQ™ Spinal Cord Stimulation with AI Technology..
11/11/202422:05PRNUSNevro Reports Third-Quarter 2024 Financial Results
08/11/202420:17EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
29/10/202421:30PRNUSNew Data Demonstrates Long-Term Improvements in Pain..
28/10/202421:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202422:30PRNUSNevro Announces New Employee Inducement Grants Under NYSE..
10/10/202422:45PRNUSNevro to Report Third-Quarter 2024 Financial Results and..
08/10/202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/9/202414:00PRNUSNevro Announces the Launch of HFX AdaptivAI™, the Only..
Apertura: Min: Max:
Chiusura: 5,78

La tua Cronologia

NYSE
NVRO
Nevro
TG
A1HTA6
AT&T
ASX
LCLNC
Los Cerros
XE
A62
Advantag
LSE
TYC
AMEX
ENAV
Mohr Sector Nav ETF
LSE
UAV
Unicorn Aim Vct
TG
A285YC
Coca Cola European Partn...
NYSE
RNST
Renasant
TG
B4B
Metro
ASX
AKNOA
Auking Mining
ASX
ADGOA
Adelong Gold
ASX
AAURB
Antilles Gold
TG
A2R8AX
Achmea BV
TSXV
TSLV
Tier One Silver
TG
9J3
Alkami Technology
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci